Extra-large 85-inch TVs are ideal for viewers seeking an immersive experience. We've picked the best models from brands like ...
In 2025, the medtech industry saw another year full of all kinds of deals in the mergers and acquisitions (M&A) arena.
Tarsh Cooper, from Tasmania, will never forget the day she lost her husband Ash after he was given a gut-wrenching diagnosis no one saw coming.
If you’ve been fold-curious but not “nearly two grand” curious, this is the kind of drop that changes the math. Right now, ...
We're old enough to remember when big screen TVs came with big time prices. They were also a lot more bulky than they are now. Fortunately, this is one area in tech where pricing now favors the ...
BRUSSELS, Dec 11 (Reuters) - The European Union reached a provisional agreement on Thursday on new rules to require all its members to screen foreign investment into the bloc in sensitive sectors such ...
Apple is reportedly testing an in-screen Face ID system that could shrink the iPhone’s front cutout to a simple hole-punch. While it won’t deliver a full under-display camera yet, it marks a major ...
All3Media International has agreed to a new multi-genre, high-volume deal in Australia, with Foxtel Group and its streamer BINGE signing for over 500 hours of content. The deal also covers a ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Brisbane-based Freenome is ...
The company plans to use the proceeds to expand its commercial and data infrastructure to support the launch of multiple blood-based cancer detection tests. Exact Sciences, which sells the stool ...
Netflix's announced Warner Bros. Discovery deal is the latest example of the company changing course. Its pivots have worked out well in the past, but biting off big M&A presents new challenges.
Freenome is taking itself public via a special purpose acquisition company, also known as a SPAC deal, to help raise funds in preparation for the planned 2026 launch of its blood-based screening tests ...